Tyk2-IN-28
Tyk2-IN-28 is an orally active and selective TYK2 inhibitor with an IC50 of 0.9 nM. Tyk2-IN-28 also inhibits JAK2 kinase activity with an IC50 of 4 nM. Tyk2-IN-28 blocks inflammatory cytokine signaling. Tyk2-IN-28 reduces paw swelling in mouse models. Tyk2-IN-28 can be used for research on psoriasis.
For research use only. We do not sell to patients.
- Formula: C23H21N9
- Molecular Weight:423.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
JAK1 10 nM (IC50) |
Tyk2 0.9 nM (IC50) |
JAK2 4 nM (IC50) |
JAK3 189 nM (IC50) |
In Vitro
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:IL-23-induced psoriasis[1]
-
Dosage:10, 20, 50 mg/kg
-
Administration:p.o.; twice daily; 6 h interval; for 8 consecutive day
-
Result:Had no significant effect on the body weight of C57BL/6 mice in the model of IL-23-induced abnormal epidermal hyperplasia of the ear.
Inhibited the increase in ear thickness and reduces ear weight.
Chemical Information
-
Molecular Weight 423.47
-
Formula C23H21N9
-
SMILES
CN1N=CC(C2=CN3N=CC=C3C(C4=CN([C@@]5(CC#N)C[C@]6(C[C@H](C#N)C6)C5)N=C4)=N2)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)